Improving Follow Up of Abnormal FITs for Better Colorectal Cancer Screening
The Problem
A fecal immunochemical test (FIT) non-invasively tests for colorectal cancer (CRC). FITs help identify patients in need of diagnostic colonoscopies, but follow-up care may be difficult for vulnerable patient populations to carry out, which exacerbates their susceptibility to CRC. FITs generally remain underutilized, especially among racial/ethnic minority and low-income populations, which makes these groups disproportionately susceptible to CRC risk.